SCM
EW icon

Seascape Capital Management’s Edwards Lifesciences EW Stock Holding History

Seascape Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-45,678
Closed -$3.66M – 98
2026
Q1 		$3.66M Buy
45,678
+1,516
+3% +$125K 1.05% 36
2025
Q4 		$3.77M Buy
44,162
+4,784
+12% +$393K 1.07% 38
2025
Q3 		$3.06M Buy
39,378
+5,056
+15% +$395K 0.88% 46
2025
Q2 		$2.68M Sell
34,322
-694
-2% -$51.8K 0.85% 46
2025
Q1 		$2.54M Buy
35,016
+754
+2% +$54K 0.89% 41
2024
Q4 		$2.54M Buy
34,262
+1,273
+4% +$89.1K 0.88% 44
2024
Q3 		$2.18M Buy
32,989
+174
+0.5% +$12.6K 0.78% 47
2024
Q2 		$3.03M Buy
32,815
+1,658
+5% +$147K 1.13% 33
2024
Q1 		$2.98M Buy
31,157
+3,391
+12% +$285K 1.11% 34
2023
Q4 		$2.12M Buy
27,766
+170
+0.6% +$11.8K 0.89% 43
2023
Q3 		$1.91M Buy
27,596
+604
+2% +$48.5K 0.91% 39
2023
Q2 		$2.55M Sell
26,992
-507
-2% -$44.1K 1.21% 35
2023
Q1 		$2.27M Sell
27,499
-58
-0.2% -$4.56K 1.16% 39
2022
Q4 		$2.06M Buy
27,557
+460
+2% +$35.5K 1.12% 41
2022
Q3 		$2.24M Buy
27,097
+333
+1% +$32K 1.53% 27
2022
Q2 		$2.54M Buy
26,764
+68
+0.3% +$7.04K 1.54% 27
2022
Q1 		$3.14M Sell
26,696
-966
-3% -$108K 1.63% 24
2021
Q4 		$3.58M Buy
27,662
+228
+0.8% +$26.6K 1.68% 21
2021
Q3 		$3.11M Buy
27,434
+620
+2% +$70.8K 1.59% 20
2021
Q2 		$2.78M Sell
26,814
-327
-1% -$30.8K 1.45% 22
2021
Q1 		$2.27M Sell
27,141
-2,639
-9% -$223K 1.26% 33
2020
Q4 		$2.72M Sell
29,780
-90
-0.3% -$7.46K 1.59% 16
2020
Q3 		$2.38M Sell
29,870
-384
-1% -$30K 1.51% 14
2020
Q2 		$2.09M Buy
+30,254
New +$2.15M 1.5% 17

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Seascape Capital Management's EW Position: Q2 2026 in Review

Seascape Capital Management sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 45,678 shares — an estimated $3.66M sold.

Seascape Capital Management first reported a position in EW in Q2 2020 and held it in 24 quarters. The position peaked at $3.77M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Seascape Capital Management reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Seascape Capital Management sold 45,678 Edwards Lifesciences shares in Q2 2026, an estimated $3.66M.
  • Seascape Capital Management first reported a position in Edwards Lifesciences in Q2 2020 and held it in 24 quarters.
  • Seascape Capital Management's Edwards Lifesciences position peaked at $3.77M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Seascape Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.